149 related articles for article (PubMed ID: 27128435)
1. Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma.
Yasui Y; Abe T; Kurosaki M; Higuchi M; Komiyama Y; Yoshida T; Hayashi T; Kuwabara K; Takaura K; Nakakuki N; Takada H; Tamaki N; Suzuki S; Nakanishi H; Tsuchiya K; Itakura J; Takahashi Y; Hashiguchi A; Sakamoto M; Izumi N
PLoS One; 2016; 11(4):e0154558. PubMed ID: 27128435
[TBL] [Abstract][Full Text] [Related]
2. Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
J Hepatol; 2014 Jul; 61(1):22-7. PubMed ID: 24607623
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
4. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
[TBL] [Abstract][Full Text] [Related]
5. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
[TBL] [Abstract][Full Text] [Related]
7. Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: a retrospective clinical-pathological study.
K-Kutala B; Bedossa P; Guedj J; Asselah T; Martinot-Peignoux M; Duval X; Marcellin P
Dig Liver Dis; 2015 Apr; 47(4):296-302. PubMed ID: 25596930
[TBL] [Abstract][Full Text] [Related]
8. [Noninvasive Estimation of Liver Fibrosis and Hepatocellular Carcinoma Development Using WFA(+)-M2BP in Chronic Hepatitis C Patients].
Tamaki N; Kurosaki M; Izumi N
Rinsho Byori; 2015 Sep; 63(9):1039-43. PubMed ID: 26731891
[TBL] [Abstract][Full Text] [Related]
9. [An analysis of clinical characteristics and risk factors of cirrhosis-related hepatocellular carcinomas in patients with hepatitis C virus infection].
Wu CH; Tian GS; Xu XY; Yu YY; Huang T
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):210-4. PubMed ID: 18364082
[TBL] [Abstract][Full Text] [Related]
10. Quantification of intratumoral collagen and elastin fibers within hepatocellular carcinoma tissues finds correlations with clinico-patho-radiological features.
Maehara J; Masugi Y; Abe T; Tsujikawa H; Kurebayashi Y; Ueno A; Ojima H; Okuda S; Jinzaki M; Shinoda M; Kitagawa Y; Oda Y; Honda H; Sakamoto M
Hepatol Res; 2020 May; 50(5):607-619. PubMed ID: 31886596
[TBL] [Abstract][Full Text] [Related]
11. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.
Huang CF; Yeh ML; Tsai PC; Hsieh MH; Yang HL; Hsieh MY; Yang JF; Lin ZY; Chen SC; Wang LY; Dai CY; Huang JF; Chuang WL; Yu ML
J Hepatol; 2014 Jul; 61(1):67-74. PubMed ID: 24613362
[TBL] [Abstract][Full Text] [Related]
12. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
Donato MF; Arosio E; Del Ninno E; Ronchi G; Lampertico P; Morabito A; Balestrieri MR; Colombo M
Hepatology; 2001 Sep; 34(3):523-8. PubMed ID: 11526538
[TBL] [Abstract][Full Text] [Related]
13. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
14. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy.
Narita Y; Genda T; Tsuzura H; Sato S; Kanemitsu Y; Ishikawa S; Kikuchi T; Hirano K; Iijima K; Wada R; Ichida T
J Gastroenterol Hepatol; 2014 Jan; 29(1):137-43. PubMed ID: 24117602
[TBL] [Abstract][Full Text] [Related]
15. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M
Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742
[TBL] [Abstract][Full Text] [Related]
16. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection.
Shibata M; Morizane T; Uchida T; Yamagami T; Onozuka Y; Nakano M; Mitamura K; Ueno Y
Lancet; 1998 Jun; 351(9118):1773-7. PubMed ID: 9635950
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
18. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
19. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
Makino Y; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Fujikawa K; Takase K; Nakano T
Anticancer Res; 2000; 20(5C):3709-15. PubMed ID: 11268443
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C.
Mahmood S; Kawanaka M; Kamei A; Izumi A; Nakata K; Niiyama G; Ikeda H; Hanano S; Suehiro M; Togawa K; Yamada G
Antioxid Redox Signal; 2004 Feb; 6(1):19-24. PubMed ID: 14713333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]